#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease refractory Intracranial germ cell tumour Thalassaemia Systemic sclerosis pulmonary Craniocerebral injury Breast cancer Cytokine release syndrome Encephalopathy neonatal Leukaemia Partial lipodystrophy Colon cancer Pleural mesothelioma Liposarcoma Peripheral primitive neuroectodermal tumour of soft tissue Candida infection More trials…

    Learn about Rare Diseases

    Pemphigoid – Life with Disease Langerhans’ cell histiocytosis Pleomorphic leiomyosarcoma – Basic Information Glomerulonephritis membranoproliferative – Basic Information Glycogen storage disease type II – Diagnostics Fabry’s disease Mantle cell lymphoma stage II – Treatment Osteosarcoma – Treatment Hyperoxaluria Uterine leiomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucart20X22 Platelet Concentrate Mesenchymal Cells Parsaclisib Hydrochloride ISPAGHULA HUSK Calcium Levofolinate Sildenafil Fludrocortisone Acetate INDAPAMIDE HEMIHYDRATE Isoflurane Citalopram Kpl-404 Abc-35B-116 GSK5458514 Clozapine Cobimetinib Tin816 Samuraciclib Ammonium Chloride Bp Efpegerglucagon More therapies…

    Learn about Your Condition

    KBG syndrome Hypogonadism male Mixed dementia Neuralgia Brain neoplasm malignant Intracranial aneurysm Endometrial adenocarcinoma Arterial disorder Ovarian cancer stage III Diabetic retinal oedema Autism spectrum disorder Cerebellar ataxia White matter lesion Extra-osseous Ewing's sarcoma Haematological malignancy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Croatia

  • Study on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia France +6
  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania
  • Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Simoctocog Alfa
    Croatia Finland France Germany Italy Spain
  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Belgium Croatia France Germany Greece Ireland +6
  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • ABBV-8736
    • Lutikizumab
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

    Recruiting

    3 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5
Previous Page
1 … 14 15 16 17 18 … 46
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Upadacitinib Pembrolizumab Rituximab Vedolizumab Trospium Chloride Xanomeline Tartrate Prednisone Ocrelizumab Semaglutide Risankizumab Lenalidomide Fluorescein Sodium Tocilizumab Guselkumab Cisplatin Sodium Chloride Bendamustine Hydrochloride Pemetrexed Lidocaine Hydrochloride Monohydrate Ruxolitinib Methylprednisolone Acetate Efgartigimod Alfa Cyclophosphamide Paracetamol Methylprednisolone Carboplatin Teriflunomide Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues Epcoritamab Adagrasib Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Abdominal infection Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute myeloid leukaemia Acute myocardial infarction Age-related macular degeneration Allogenic stem cell transplantation Alopecia areata Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell type acute leukaemia Bipolar disorder Bipolar I disorder Bladder cancer Breast cancer Breast cancer metastatic Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia refractory Chronic obstructive pulmonary disease Chronic spontaneous urticaria Coagulopathy Coeliac disease Colitis ulcerative Constipation Crohn's disease Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dermatitis atopic Dermatomyositis Diabetic foot infection Diabetic retinal oedema Diffuse large B-cell lymphoma Dry age-related macular degeneration Epidermolysis bullosa Factor IX deficiency Factor VIII deficiency Familial hypertriglyceridaemia Focal segmental glomerulosclerosis Follicular lymphoma Generalised tonic-clonic seizure Gingival bleeding Haemophilia A with anti factor VIII Haemophilia B with anti factor IX Haemorrhage prophylaxis Hepatic cirrhosis Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hidradenitis Hodgkin's disease Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hyperlipidaemia Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Idiopathic generalised epilepsy Idiopathic pulmonary fibrosis IgA nephropathy Immune thrombocytopenia Interstitial lung disease Iron deficiency Lupus nephritis Major depression Mania Medullary thyroid cancer Metabolic dysfunction-associated steatohepatitis Metastatic malignant melanoma Multiple sclerosis Multiple sclerosis relapse Myelofibrosis Myeloproliferative neoplasm Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neurodermatitis Neurogenic bladder Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Noonan syndrome Obesity Osteoarthritis Ovarian cancer Ovarian cancer metastatic Overweight Partial seizures Pemphigoid Plasma cell myeloma Plasma cell myeloma refractory Pneumonia bacterial Polycythaemia vera Pouchitis Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pyelonephritis Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Renal disorder Rheumatoid arthritis Schizophrenia Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small for dates baby Spinal muscular atrophy Squamous cell carcinoma of head and neck Status epilepticus Systemic lupus erythematosus Systemic scleroderma Tardive dyskinesia Turner's syndrome Type 2 diabetes mellitus Urinary tract infection

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!